STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Cash flows from operating activities
Net income	$ 2,251,822	$ 1,499,136
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment	98,992	112,441
Amortization of capitalized computer software development costs	494,537	490,051
Amortization of Intellectual property	377,500	377,500
Stock-based compensation	120,249	150,624
Deferred income taxes	(162,928)	159,968
(Increase) decrease in
Accounts receivable	(2,214,374)	(536,612)
Revenues in excess of billings	(61,433)	(92,310)
Prepaid income taxes	(240,116)	422,125
Prepaid expenses and other assets	72,566	8,095
Increase (decrease) in
Accounts payable	(83,329)	(69,307)
Accrued payroll and other expenses	11,508	(397,090)
Accrued bonus	(60,500)	(72,000)
Billings in excess of revenues	65,763	(249,637)
Accrued income taxes	(43,602)	0
Other liabilities	(9,929)	(9,930)
Deferred revenue	35,686	14,576
Net cash provided by (used in) operating activities	652,412	1,807,630
Cash flows from investing activities
Purchases of property and equipment	(2,501)	(19,159)
Cash used to purchase Cognigen	0	(2,080,000)
Cash received in acquisition	0	190,184
Capitalized computer software development costs	(545,223)	(730,855)
Net cash provided by (used in) investing activities	(547,724)	(2,639,830)
Cash flows from financing activities
Payment of dividends	(1,700,700)	(1,684,660)
Proceeds from the exercise of stock options	107,730	4,973
Net cash (used in) financing activities of continuing operations	(1,592,970)	(1,679,687)
Net increase (decrease) in cash and cash equivalents	(1,488,282)	(2,511,887)
Cash and cash equivalents, beginning of year	8,551,275	8,614,929
Cash and cash equivalents, end of period	7,062,993	6,103,042
Supplemental disclosures of cash flow information
Interest paid	0	0
Income taxes paid	1,596,000	76,519
Non-Cash Investing and Financing
Stock issued for acquisition of Cognigen Corporation	0	3,277,170
Creation of contract liability for acquisition of Cognigen Corporation	$ 0	$ 1,854,404